Solventum (SOLV) Cash from Investing Activities (2023 - 2026)
Solventum (SOLV) reported Cash from Investing Activities of -$77.0 million for Q1 2026, up 32.46% on a YoY basis from -$58.1 million in Q1 2025, and up 89.66% quarter-over-quarter from -$745.0 million in Q4 2025.
Solventum (SOLV) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Solventum has reported Cash from Investing Activities for 4 years, with the latest figure at -$77.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 32.46% year-over-year to -$77.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.8 billion (up 822.96% YoY), and the FY2025 full-year result was $2.8 billion, up 836.05% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$77.0 million, up from -$745.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $3.8 billion in Q3 2025, with the low at -$745.0 million in Q4 2025.
- Historically, Cash from Investing Activities has averaged $162.3 million across 4 years, with a median of -$88.0 million in 2023.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities tumbled 1450.0% — and 2025, when it jumped 4149.46%.
- Solventum's Cash from Investing Activities stood at -$88.0 million in 2023, then sank by 44.32% to -$127.0 million in 2024, then plunged by 486.61% to -$745.0 million in 2025, then soared by 89.66% to -$77.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$77.0 million (Q1 2026), -$745.0 million (Q4 2025), and $3.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -65.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.00 Mn |
| Mar 31, 2026 | -77.00 Mn |
| Dec 31, 2025 | -745.00 Mn |
| Dec 31, 2025 | -745.00 Mn |
| Sep 30, 2025 | 3.77 Bn |
| Sep 30, 2025 | 3.77 Bn |
| Jun 30, 2025 | -110.00 Mn |
| Jun 30, 2025 | -110.00 Mn |
| Mar 31, 2025 | -114.00 Mn |
| Mar 31, 2025 | -114.00 Mn |
| Dec 31, 2024 | -127.00 Mn |
| Dec 31, 2024 | -127.00 Mn |
| Sep 30, 2024 | -93.00 Mn |
| Sep 30, 2024 | -93.00 Mn |
| Jun 30, 2024 | -58.00 Mn |
| Jun 30, 2024 | -58.00 Mn |
| Mar 31, 2024 | -102.00 Mn |
| Mar 31, 2024 | -102.00 Mn |
| Dec 31, 2023 | -88.00 Mn |
| Dec 31, 2023 | -88.00 Mn |